Literature DB >> 31543403

Fatty Liver Disease Caused by High-Alcohol-Producing Klebsiella pneumoniae.

Jing Yuan1, Chen Chen2, Jinghua Cui3, Jing Lu4, Chao Yan3, Xiao Wei4, Xiangna Zhao4, NanNan Li3, Shaoli Li3, Guanhua Xue3, Weiwei Cheng4, Boxing Li4, Huan Li4, Weishi Lin4, Changyu Tian4, Jiangtao Zhao4, Juqiang Han5, Daizhi An4, Qiong Zhang2, Hong Wei6, Minghua Zheng7, Xuejun Ma8, Wei Li9, Xiao Chen3, Zheng Zhang3, Hui Zeng2, Sun Ying10, JianXin Wu3, Ruifu Yang11, Di Liu12.   

Abstract

The underlying etiology of nonalcoholic fatty liver disease (NAFLD) is believed to be quite varied. Changes in the gut microbiota have been investigated and are believed to contribute to at least some cases of the disease, though a causal relationship remains unclear. Here, we show that high-alcohol-producing Klebsiella pneumoniae (HiAlc Kpn) is associated with up to 60% of individuals with NAFLD in a Chinese cohort. Transfer of clinical isolates of HiAlc Kpn by oral gavage into mice induced NAFLD. Likewise, fecal microbiota transplant (FMT) into mice using a HiAlc-Kpn-strain-containing microbiota isolated from an individual with NASH induced NAFLD. However, selective elimination of the HiAlc Kpn strain before FMT prevented NAFLD in the recipient mice. These results suggest that at least in some cases of NAFLD an alteration in the gut microbiome drives the condition due to excess endogenous alcohol production.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Klebsiella pneumoniae; alcohol-producing bacteria; endo-NAFLD; fatty liver disease; fecal microbiota transplantation; gut microbiota; high-fat diet; liver transcriptome; metagenomics; mice model

Year:  2019        PMID: 31543403     DOI: 10.1016/j.cmet.2019.08.018

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  86 in total

Review 1.  Gut microbiota in non-alcoholic fatty liver disease and alcohol-related liver disease: Current concepts and perspectives.

Authors:  Juan P Arab; Marco Arrese; Vijay H Shah
Journal:  Hepatol Res       Date:  2020-01-13       Impact factor: 4.288

Review 2.  Gut microbiota in human metabolic health and disease.

Authors:  Yong Fan; Oluf Pedersen
Journal:  Nat Rev Microbiol       Date:  2020-09-04       Impact factor: 60.633

3.  ADH1B∗2 Is Associated With Reduced Severity of Nonalcoholic Fatty Liver Disease in Adults, Independent of Alcohol Consumption.

Authors:  Eduardo Vilar-Gomez; Silvia Sookoian; Carlos Jose Pirola; Tiebing Liang; Samer Gawrieh; Oscar Cummings; Wanqing Liu; Naga P Chalasani
Journal:  Gastroenterology       Date:  2020-05-23       Impact factor: 22.682

Review 4.  Intestinal virome and therapeutic potential of bacteriophages in liver disease.

Authors:  Cynthia L Hsu; Yi Duan; Derrick E Fouts; Bernd Schnabl
Journal:  J Hepatol       Date:  2021-08-24       Impact factor: 25.083

Review 5.  Host-microbial interactions in metabolic diseases: from diet to immunity.

Authors:  Ju-Hyung Lee; Joo-Hong Park
Journal:  J Microbiol       Date:  2022-05-05       Impact factor: 3.422

Review 6.  Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders.

Authors:  Judith Aron-Wisnewsky; Chloé Vigliotti; Julia Witjes; Phuong Le; Adriaan G Holleboom; Joanne Verheij; Max Nieuwdorp; Karine Clément
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-03-09       Impact factor: 46.802

7.  Lactobacillus and Pediococcus ameliorate progression of non-alcoholic fatty liver disease through modulation of the gut microbiome.

Authors:  Na Young Lee; Sang Jun Yoon; Dae Hee Han; Haripriya Gupta; Gi Soo Youn; Min Jea Shin; Young Lim Ham; Min Jung Kwak; Byung Yong Kim; Jeong Seok Yu; Do Yup Lee; Tae-Sik Park; Si-Hyun Park; Byoung Kook Kim; Hyun Chae Joung; In Suk Choi; Ji Taek Hong; Dong Joon Kim; Sang Hak Han; Ki Tae Suk
Journal:  Gut Microbes       Date:  2020-01-22

Review 8.  Microbiota and Fatty Liver Disease-the Known, the Unknown, and the Future.

Authors:  Sonja Lang; Bernd Schnabl
Journal:  Cell Host Microbe       Date:  2020-08-12       Impact factor: 21.023

9.  New Developments in Microbiome in Alcohol-Associated and Nonalcoholic Fatty Liver Disease.

Authors:  Phillipp Hartmann; Bernd Schnabl
Journal:  Semin Liver Dis       Date:  2021-01-14       Impact factor: 6.115

Review 10.  Gut microbiome, liver immunology, and liver diseases.

Authors:  Rui Wang; Ruqi Tang; Bo Li; Xiong Ma; Bernd Schnabl; Herbert Tilg
Journal:  Cell Mol Immunol       Date:  2020-12-14       Impact factor: 11.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.